Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stock-based Compensation - Stock Compensation Activity (Details)

v3.22.0.1
Note 5 - Stock-based Compensation - Stock Compensation Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Outstanding (in shares) 24,899,014  
Outstanding, weighted average exercise price (in dollars per share) $ 0.29  
Outstanding, weighted average remaining contractual term (Year) 1 year 8 months 1 day 1 year 9 months 29 days
Outstanding, aggregate intrinsic value $ 750 $ 140,151
Awarded (in shares) 250,000  
Awarded, weighted average exercise price (in dollars per share) $ 0.10  
Forfeited/Cancelled (in shares) (1,969,016)  
Forfeited/Cancelled, weighted average exercise price (in dollars per share) $ 0.44  
Outstanding (in shares) 23,179,998 24,899,014
Outstanding, weighted average exercise price (in dollars per share) $ 0.28 $ 0.29
Vested (in shares) 17,759,551  
Vested, weighted average exercise price (in dollars per share) $ 0.33  
Vested, weighted average remaining contractual term (Year) 2 years 3 days  
Vested and expected to vest (in shares) 23,179,998  
Vested and expected to vest, weighted average exercise price (in dollars per share) $ 0.28  
Vested and expected to vest, weighted average remaining contractual term (Year) 1 year 8 months 1 day  
Vested and expected to vest, aggregate intrinsic value $ 750